CAPS vs GSK · rev $34.1M vs P/E 13, $103.31B cap
Capstone Holding Corp. Common Stock (CAPS) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Capstone Holding Corp. Common Stock (CAPS) is a building materials company listed on NASDAQ.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported CAPS revenue for 2026-06-30 was $34.1M. Net income was -$3.3M. CAPS currently screens at market cap $3.7M.
GSK does not have a complete income-statement cache yet.
CAPS currently screens at market cap $3.7M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the CAPS and GSK stock pages for the full models.
Not investment advice.